Skip to main
GRDN
GRDN logo

GRDN Market Capitalization Overview

Market Cap: $1.34B as of Jul 2, 2025

$1.34B
Past Month-$37.55M (2.74%)
As of Jul 2, 2025, GRDN has a market capitalization of $1.34B. Over the past 30 days, its market cap has increased by 0.52%, while in the last 12 months, it has increased by 3.93%.

Market capitalization represents the total value of Guardian Pharmacy Services Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

GRDN Market Cap Formula = Stock Price * Shares Outstanding

The market cap of GRDN helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

GRDN Market Cap History

DateMarket CapChange
Jul 1, 2025$1.39B+0.52%
Jun 2, 2025$1.38B-12.13%
May 1, 2025$1.57B+17.94%
Apr 1, 2025$1.33B+11.09%
Mar 3, 2025$1.20B-14.97%
Feb 3, 2025$1.41B+11.81%
Jan 2, 2025$1.26B-18.08%

GRDN End of Year Market Cap History

DateMarket CapChange
2025$1.34B+3.93%
2024$1.29B

FAQs About Guardian Pharmacy Services Inc (GRDN) Market Cap

As of Jul 2, 2025, the market capitalization of GRDN is $1.34B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Guardian Pharmacy Services Inc’s market capitalization has decreased by -2.74%, changing from $1.38B to $1.34B as of Jul 2, 2025.

In the last 3 months, Guardian Pharmacy Services Inc’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Guardian Pharmacy Services Inc’s market capitalization increased from – in January to $1.29B in December, reflecting a — change.

Guardian Pharmacy Services Inc (GRDN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.